Dr. Douglas McMillin is an Expert Manager with Catenion and lives in Cambridge, MA USA.
Doug has experience in cancer biology, tumor microenvironment, immuno-oncology, gene therapy, metabolic diseases, drug delivery, and diagnostics. He previously was the Founder/President of an early-stage oncology drug discovery company and has consulted for multiple early stage companies.
In his free time, Doug enjoys mountain biking, golf, music, and cooking.
Doug has a PhD in Pharmacology from Emory University (Atlanta, GA USA) and completed a post-doctoral fellowship at the Dana-Farber Cancer Institute, Harvard Medical School in Boston, MA USA and has published >35 peer-reviewed publications, including 1st author publications in Nature Medicine, Nature Reviews Drug Discovery, Blood, Human Gene Therapy, and OncoImmunology.
- Preclinical data analysis
- Market research
- Competitive analysis
- IP evaluation
- Business plan evaluation and development